Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Paris
Clinical trial register · France

Clinical Trials in Paris, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9722 matching records held by the registry are in this view. Synced 29 Oct 2026, 03:20 UTC
9722
Studies in scope
all four open statuses
6047
Recruiting now
open to new participants
1031
Lead sponsors
across recruiting studies
Top sites
Paris 2823 Lyon 1395 Bordeaux 1389 Marseille 1291 Lille 1281
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Assistance Publique - Hôpitaux de Paris604 Novartis Pharmaceuticals68 Fondation Ophtalmologique Adolphe de Rothschild67 Institut National de la Santé Et de la Recherche Médicale, France64 AstraZeneca64
Site location
Paris2823 Lyon1395 Bordeaux1389 Marseille1291 Lille1281
All 809 locations
Target enrolment
to

Trials with a site in Paris

2823 of 9722 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Active, closed
Centre d'Etude des Cellules Souches
Phase 1/2
7
Paris
2019-08-19
Active, closed
Sanofi
Observational
1,860
Argenteuil, Bordeaux, Lille, Marseille, Martigues, Nantes, Paris, Toulouse
2019-08-15
Recruiting
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials
NCT04064060Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis
DrugLuspatercept
Celgene
Phase 3
665
Angers, Créteil, La Tronche, Lille, Marseille, Paris, Pessac, Pierre-Bénite
2019-08-12
Recruiting
Assistance Publique - Hôpitaux de Paris
Not applicable
210
Paris
2019-08-02
Recruiting
Global Coalition for Adaptive Research
Phase 2/3
2,250
Bron, Marseille, Paris
2019-07-30
Active, closed
Pfizer
Phase 3
51
Bron, Paris
2019-07-29
Active, closed
Novartis Pharmaceuticals
Phase 3
253
Créteil, Marseille, Paris
2019-07-26
Active, closed
Assistance Publique - Hôpitaux de Paris
Phase 3
436
Paris
2019-07-25
Recruiting
Oxford BioTherapeutics Ltd
Phase 1
200
Marseille, Paris, Rennes, Strasbourg, Villejuif
2019-07-25
Active, closed
Assistance Publique - Hôpitaux de Paris
Not applicable
50
Paris
2019-07-24
Active, closed
Dizal Pharmaceuticals
Phase 1/2
315
Angers, Bron, Dijon, Hellemmes-Lille, Marseille, Montpellier, Paris, Poitiers
2019-07-09
Active, closed
Long Term Extension Study in Patients With Primary Hyperoxaluria
NCT04042402Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2 (PH2), Kidney Diseases, Urologic Diseases
DrugDcr-Phxc
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Phase 3
75
Bron, Paris
2019-07-09
Active, closed
MIF Involvement in AML
NCT03918655Acute Myeloid Leukemia
Assistance Publique - Hôpitaux de Paris
Observational
186
Paris
2019-07-07
Recruiting
Respiratory Support in Chronic Obstructive Pulmonary Disease (COPD) Patients
NCT03890224Chronic Obstructive Pulmonary Disease, COPD Exacerbation
Clinact
Not applicable
400
Paris
2019-07-04
Active, closed
Novo Nordisk A/S
Phase 2
62
Angers, Le Kremlin-Bicêtre, Marseille, Marseille Cédex 05, Paris, Toulouse
2019-07-04
Recruiting
High Resolution, High-speed Multimodal Ophthalmic Imaging
NCT04129021Retinitis Pigmentosa, Maculopathy, Age Related, Macular Dystrophy, Macular Edema
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Not applicable
1,200
Paris
2019-07-03
Active, closed
Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL
NCT03960840Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia
DrugIbrutinib
Novartis Pharmaceuticals
Phase 1/2
217
Marseille, Paris, Pierre-Bénite, Rennes
2019-06-26
Active, closed
Exelixis
Phase 3
855
Bordeaux, Le Mans, Lyon, Montpellier, Nice, Paris, Reims, Rennes
2019-06-25
Active, closed
AstraZeneca
Phase 3
923
Brest, Lyon, Marseille, Montpellier, Nice, Paris, Saint-Herblain, Villejuif
2019-06-25
Active, closed
Novartis Pharmaceuticals
Phase 2
121
Paris
2019-06-24
Active, closed
Janssen Research & Development, LLC
Phase 3
2,517
Angers, Besançon, Bordeaux, Créteil, Lyon, Nantes, Paris, Quint-Fonsegrives
2019-06-11
Recruiting
Benjamin Terrier
Observational
100
Paris
2019-06-01
Active, closed
Eisai Inc.
Phase 2
100
Marseille, Bordeaux, Paris, Rennes, Toulouse
2019-05-31
Active, closed
LEO Pharma
Phase 2
131
Bordeaux, Nice, Paris, Reims
2019-05-29
Recruiting
HighLife SAS
Not applicable
120
Toulouse, Lille, Lyon, Massy, Nantes, Paris, Pessac, Rennes
2019-05-28
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
104
Clermont-Ferrand, Paris, Saint-Denis
2019-05-28
Active, closed
Nuvaira, Inc.
Not applicable
464
Grenoble, Toulouse, Brest, Montpellier, Nice, Paris, Reims, Strasbourg
2019-05-23
Active, closed
Assistance Publique - Hôpitaux de Paris
Not applicable
363
Paris
2019-05-23
Active, closed
AbbVie
Phase 1
150
Saint-Herblain, Paris, Lyon, Clermont-Ferrand
2019-05-21
Active, closed
Celgene
Phase 1/2
438
Bordeaux, Créteil, Lille, Montpellier, Paris, Pierre-Bénite, Rouen, Toulouse
2019-05-20
Active, closed
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer (CHIPPI)
NCT03842982Ovary Neoplasms, Ovarian Cancer, Ovarian Carcinoma
DrugHipec
Centre Oscar Lambret
Phase 3
362
Angers, Bordeaux, Caen, Clermont-Ferrand, Lille, Marseille, Montpellier, Paris
2019-05-03
Recruiting
LISA Post Market Clinical Follow-Up Study: Documentation of Clinical Outcomes After Surgery With LISA Implant
NCT04631133Chronic Low-back Pain, Herniated Disc, Degenerative Disc Disease, Lumbar Canal Stenosis
BACKBONE
Observational
136
Bordeaux, Lyon, Paris
2019-04-17
Active, closed
Assistance Publique - Hôpitaux de Paris
Not applicable
14
Paris, Neuilly-sur-Seine
2019-04-16
Active, closed
AstraZeneca
Phase 3
810
Clichy, Dijon, Montpellier, Nice, Paris, Pessac, Poitiers
2019-04-16
Active, closed
Blueprint Medicines Corporation
Phase 2
251
Marseille, Paris, Toulouse
2019-04-16
Active, closed
Assistance Publique - Hôpitaux de Paris
Not applicable
73
Paris
2019-04-11
Recruiting
Eli Lilly and Company
Phase 3
190
Bron, Le Kremlin-Bicêtre, Nîmes, Paris, Poitiers
2019-04-05
Active, closed
A Study to Evaluate Efficacy, Safety, Tolerability and Exposure After a Repeat-dose of Sepofarsen (QR-110) in LCA10 (ILLUMINATE)
NCT03913143Leber Congenital Amaurosis 10, Blindness, Leber Congenital Amaurosis, Vision Disorders
DrugSepofarsen
ProQR Therapeutics
Phase 2/3
36
Paris, Strasbourg
2019-04-04
Active, closed
Eisai Inc.
Phase 3
1,906
Marseille, Montpellier, Nantes, Paris, Toulouse, Bron, Strasbourg
2019-03-27
Active, closed
Avelumab Program Rollover Study
NCT03815643Solid Tumors
DrugAvelumab
EMD Serono Research & Development Institute, Inc.
Phase 3
205
Besançon, Lille, Nantes, Nice, Paris, Pessac, Poitiers, Strasbourg
2019-03-22
Active, closed
Institut de Recherches Internationales Servier
Phase 3
856
Avignon, Besançon, Brest, Lyon, Montbéliard, Nice, Paris, Pessac
2019-03-21
Active, closed
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
NCT03845166Neoplasm Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma, Metastatic Castration-resistant Prostate Cancer
DrugsZanzalintinib·Avelumab·Tecentriq·Atezolizumab
Exelixis
Phase 1
325
Clermont, Saint-Herblain, Bordeaux, Caen, Marseille, Paris, Pierre-Bénite, Poitiers
2019-03-20
Recruiting
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
NCT03664609Parkinson Disease, Essential Tremor, Dystonia
Boston Scientific Corporation
Observational
5,000
Paris
2019-03-12
Recruiting
French Cohort of Myocardial Infarction Evaluation
NCT04050956Acute Myocardial Infarction
Assistance Publique - Hôpitaux de Paris
Observational
30,000
Paris
2019-03-11
Active, closed
Durvalumab and Tremelimumab for Pediatric Malignancies
NCT03837899Pediatric Cancer, Solid Tumor Pediatric, Hematological Malignancies
DrugDurvalumab
AstraZeneca
Phase 1/2
50
Lille, Marseille, Paris
2019-03-07
Active, closed
Groupe Hospitalier Diaconesses Croix Saint-Simon
Observational
600
Paris
2019-03-01
Recruiting
Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care
NCT03882580Cardiovascular Complication, Cardiovascular Insufficiency, Cardiac Complication, Oncologic Complications
Groupe Hospitalier Pitie-Salpetriere
Observational
5,000
Paris
2019-03-01
Active, closed
Acerta Pharma BV
Phase 3
984
Montpellier, Paris, Rennes, Rouen, Toulouse, Villejuif
2019-02-25
Recruiting
Institut Pasteur
Observational
100
Le Kremlin-Bicêtre, Paris
2019-02-19
Active, closed
University Hospital, Montpellier
Phase 2/3
113
Montpellier, Nantes, Paris
2019-02-18
Active, closed
Deciphera Pharmaceuticals, LLC
Phase 3
453
Bordeaux, Dijon, Lille, Lyon, Marseille, Paris, Poitiers, Saint-Herblain
2019-02-08
Recruiting
University Hospital, Tours
Observational
150
Bordeaux, Grenoble, Lyon, Marseille, Nantes, Nice, Paris, Rennes
2019-02-04
Active, closed
Fondation Hôpital Saint-Joseph
Not applicable
279
Le Plessis-Robinson, Paris, Saint-Denis
2019-02-01
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Besançon, Bordeaux, Clermont-Ferrand, Lyon, Montpellier, Nancy, Nice, Paris
2019-01-25
Recruiting
Travere Therapeutics, Inc.
Phase 1/2
39
Paris
2019-01-22
Recruiting
Hospices Civils de Lyon
Not applicable
196
Fort-de-France-La Martinique, Créteil, Le Kremlin-Bicêtre, Lyon, Paris, Pontoise
2019-01-16
Active, closed
Ancora Heart, Inc.
Not applicable
132
Pessac, Bron, Marseille, Paris, Strasbourg, Toulouse
2019-01-15
Recruiting
RECORDATI GROUP
Observational
95
Bordeaux, Marseille, Nancy, Paris, Rouen, Strasbourg
2019-01-15
Recruiting
Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy
NCT03509064Primary Sjögren Syndrome, Small Fiber Neuropathy, Quality of Life, Medico-economic Impact
Assistance Publique - Hôpitaux de Paris
Observational
100
Paris
2019-01-14
Active, closed
AstraZeneca
Phase 2
367
Dijon, Marseille, Nantes, Paris, Rennes
2019-01-09
Active, closed
AstraZeneca
Phase 3
1,407
Besançon, Bordeaux, Limoges, Lyon, Marseille, Nantes, Paris, Saint-Herblain
2019-01-04
Active, closed
Gustave Roussy, Cancer Campus, Grand Paris
Phase 2
45
Paris, Villejuif, Bordeaux, Créteil, Lille, Lyon, Toulouse, Vandœuvre-lès-Nancy
2019-01-02
Recruiting
JOint Use of Database to Identify Risk Factors of CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors
NCT04294771Myocarditis, Cardiomyopathies, Heart Diseases, Cardiovascular Diseases
Groupe Hospitalier Pitie-Salpetriere
Observational
500,000
Paris
2019-01-01
Active, closed
Jules Bordet Institute
Phase 1/2
129
Besançon, Bordeaux, Dijon, Marseille, Nice, Paris, Poitiers, Rouen
2018-12-28
Active, closed
Novartis Pharmaceuticals
Phase 3
1,882
Lille, Montpellier, Nantes, Nice, Nîmes, Paris, Strasbourg
2018-12-28
Active, closed
W.L.Gore & Associates
Observational
280
Paris
2018-12-18
Active, closed
Merck Sharp & Dohme LLC
Phase 3
714
Nice, Marseille, Toulouse, Villejuif, Avignon, Paris
2018-12-17
Active, closed
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension
NCT03614260Hypertension, Vascular Diseases, Cardiovascular Diseases
ReCor Medical, Inc.
Not applicable
224
Bordeaux, Lille, Paris
2018-12-14
Active, closed
UNICANCER
Phase 2
79
Bordeaux, Clermont-Ferrand, Dijon, Lille, Montpellier, Mougins, Nice, Paris
2018-12-14
Recruiting
Pulmonary Hemodynamics During Exercise - Research Network
NCT03954574Pulmonary Circulation Diseases
Medical University of Graz
Observational
1,500
Nancy, Paris
2018-12-01
Active, closed
AstraZeneca
Phase 3
724
Bobigny, Clichy, Grenoble, Montpellier, Nice, Paris, Pessac, Toulouse
2018-11-30
Recruiting
Biology of Cerebral Arteriovenous Malformations and Prognosis of Cerebral Arteriovenous Malformations
NCT03676868Cerebral Arteriovenous Malformations, Ruptured or Unruptured Cerebral Arteriovenous Malformations
Fondation Ophtalmologique Adolphe de Rothschild
Observational
300
Paris
2018-11-20
Recruiting
Implanted Phrenic Nerve Stimulator Database.
NCT03659019External Mechanical Ventilatory Support
Assistance Publique - Hôpitaux de Paris
Observational
100
Paris
2018-11-20
Active, closed
IRCCS San Raffaele
Observational
200
Marseille, Paris
2018-10-30
Active, closed
Janssen Research & Development, LLC
Phase 3
84
Bordeaux, Paris
2018-10-29
Active, closed
Blinatumomab in High-risk B-cell Precursor Acute Lymphoblastic Leukemia
NCT03709719Acute Lymphoblastic Leukemia, Adult B-Cell
DrugBlinatumomab
Assistance Publique - Hôpitaux de Paris
Phase 2
95
Paris
2018-10-20
Active, closed
Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence
NCT03438552Local Recurrence of Malignant Tumor of Prostate
UNICANCER
Not applicable
57
Caen, Clermont-Ferrand, Dijon, Lille, Lyon, Montpellier, Paris, Rennes
2018-10-18
Active, closed
Randomized Trial of Electronic Cigarettes With or Without Nicotine in Smoking Cessation.
NCT03630614Smoking Cessation, Smoking, Cigarette, Electronic Cigarette
Assistance Publique - Hôpitaux de Paris
Phase 3
650
Paris
2018-10-17
Active, closed
AbbVie
Phase 2
270
Marseille, Bordeaux, Lille, Paris, Bron, Lyon, Créteil, Villejuif
2018-10-10
Active, closed
Exelixis
Phase 3
187
Dijon, Bordeaux, Angers, Marseille, Besançon, Lyon, Nice, Paris
2018-10-05
Active, closed
Hospices Civils de Lyon
Phase 3
108
Aix-en-Provence, Besançon, Bordeaux, Colmar, Lille, Lyon, Marseille, Paris
2018-10-02
Active, closed
GenSight Biologics
Phase 1/2
10
Paris
2018-09-26
Recruiting
Hoffmann-La Roche
Phase 3
1,000
Bordeaux, Lyon, Marseille, Paris
2018-09-20
Active, closed
Assistance Publique - Hôpitaux de Paris
Phase 3
150
Paris
2018-09-17
Active, closed
Sepsis in the ICU-II
NCT04695119Septic Shock, Sepsis, Cardiomyopathies, Organ Failure, Multiple
Linkoeping University
Observational
379
Dijon, Paris
2018-09-17
Active, closed
Marc van Sambeek
Observational
156
Paris
2018-09-11
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3
315
Villejuif, Lille, Paris, Rennes
2018-08-29
Active, closed
Institut Paoli-Calmettes
Phase 2
52
Amiens, Avignon, Bordeaux, Caen, Dijon, Lyon, Paris, Rouen
2018-08-29
Recruiting
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
NCT03583710ENSAT Stage I Adrenal Cortex Carcinoma, ENSAT Stage II Adrenal Cortex Carcinoma, ENSAT Stage III Adrenal Cortex Carcinoma
DrugsMitotane·Cis-platinum·CDDP·Etoposide
M.D. Anderson Cancer Center
Phase 3
240
Angers, Besançon, Brest, Dijon, Lyon, Marseille, Nantes, Paris
2018-08-20
Active, closed
Hoffmann-La Roche
Phase 3
257
Angers, Marseille, Paris, Villejuif
2018-08-16
Active, closed
Daiichi Sankyo
Phase 1/2
65
Lyon, Paris, Toulouse
2018-08-15
Recruiting
Sanofi
Phase 2
51
Bron, Montpellier, Paris
2018-08-09
Active, closed
Actelion
Phase 2
63
Montpellier, Paris, Toulouse
2018-07-23
Recruiting
Celgene
Phase 2/3
1,541
Creteil-Paris, Lille, Lyon, Marseille, Montpellier, Nantes, Paris, Pessac
2018-07-19
Active, closed
Eli Lilly and Company
Phase 3
1,058
Amiens, Chambray-lès-Tours, Lille, Montpellier, Neuilly-sur-Seine, Nice, Paris, Pau
2018-07-18
Recruiting
University Hospital, Grenoble
Not applicable
90
Amiens, Angers, Besançon, Bordeaux, Clichy, Grenoble, Paris, Poitiers
2018-07-17
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer
NCT03505320Pharmacokinetics of Zolbetuximab, Gastric Cancer, Gastro-esophageal Junction (GEJ) Cancer, Pharmacokinetics of Oxaliplatin
DrugsFolinic acid·Zolbetuximab·Fluorouracil·Leucovorin
Astellas Pharma Global Development, Inc.
Phase 2
143
Pessac, Poitiers, Brest, Paris
2018-06-29
Recruiting
Gérond'if
Observational
2,000
Paris
2018-06-26
Active, closed
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037DLBCL, High-grade B-cell Lymphoma (HGBCL), Primary Mediastinal Large B-cell Lymphoma (PMBCL), FL
DrugEpcoritamab
Genmab
Phase 1/2
666
Créteil, Montpellier, Paris, Pierre-Bénite, Rouen, Tours
2018-06-26
Recruiting
University Hospital, Lille
Phase 2
28
Lille, Paris
2018-06-25
Active, closed
A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.
NCT03504397Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsFolinic acid·Zolbetuximab·Fluorouracil·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
565
Dijon, Brest, Rennes, Besançon, Montpellier, Paris, Saint-Herblain, Nice
2018-06-21
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Not applicable
500
Villejuif, Paris
2018-06-14
Recruiting
University Hospital, Montpellier
Phase 2
40
Amiens, Angers, Bordeaux, Dijon, Montpellier, Paris, Villejuif
2018-06-11
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
500
Paris
2018-06-06
Active, closed
French Cardiology Society
Observational
218
Le Plessis-Robinson, Paris, Pessac, Toulouse
2018-06-01
Recruiting
Semantic and Syntactic Computerized Analysis of Free Speech
NCT03525054Psychotic Disorders, Psychosis, Schizophrenia and Related Disorders, Schizophrenia Prodromal
University Hospital, Brest
Observational
215
Brest, Caen, Paris
2018-05-18
Active, closed
Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy
NCT03418844Germ Cell Tumor, Sex Cord Stromal Tumor, Malignant Non-epithelial Ovarian Tumors
Centre Francois Baclesse
Not applicable
268
Paris, Angers, Besançon, Bordeaux, Bourg-en-Bresse, Caen, Clermont-Ferrand, Lyon
2018-05-07
Active, closed
Centre Hospitalier Universitaire de Besancon
Not applicable
989
Saint-Denis, Paris, Amiens, Besançon, Bordeaux, Caen, Clamart, Clermont-Ferrand
2018-05-03
Active, closed
GlaxoSmithKline
Phase 2
237
Le Mans, Lille, Marseille, Paris, Pessac, Pierre-Bénite, Toulouse
2018-05-03
Recruiting
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
NCT03526835Advanced/Metastatic Solid Tumors, Colorectal Cancer, Gastric Cancer, Gastroesophageal-junction Cancer
DrugPetosemtamab
Merus B.V.
Phase 1/2
560
Bordeaux, Lyon, Marseille, Montpellier, Nice, Paris, Rouen
2018-05-02
Active, closed
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 2
50
Paris
2018-05-02
By invitation
International Registry of Congenital Portosystemic Shunt (IRCPSS)
NCT06041906Congenital Portosystemic Shunt, CPSS (Congenital Portosystemic Shunt)
Prof. Valérie Mc Lin
Observational
500
Clichy, Le Kremlin-Bicêtre, Paris
2018-04-26
Active, closed
Pyruvate Kinase Deficiency Global Longitudinal Registry
NCT03481738Pyruvate Kinase Deficiency
Agios Pharmaceuticals, Inc.
Observational
500
Paris
2018-04-23
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2
55
Brest, Bron, Caen, La Tronche, Marseille, Paris, Toulouse, Villejuif
2018-04-11
Active, closed
Bristol-Myers Squibb
Phase 2/3
714
Rennes, Amiens, Bordeaux, Lille, Marseille, Paris, Pierre-Bénite, Poitiers
2018-04-11
Active, closed
Merck Sharp & Dohme LLC
Phase 2
340
Lyon, Marseille, Bordeaux, Lille, Villejuif, Paris
2018-04-09
Active, closed
Janssen Research & Development, LLC
Phase 1/2
125
Angers, Bordeaux, Caen, La Rochelle, Lyon, Marseille, Paris, Strasbourg
2018-04-05
Recruiting
Atlas of Human Cognition by SEEG (MAPCOG-SEEG)
NCT03644732Refractory Epilepsy, Focal Epilepsy
University Hospital, Grenoble
Observational
200
Grenoble, Nancy, Paris, Rennes
2018-04-05
Active, closed
AbbVie
Phase 2
156
Limoges, Tours, Nantes, Villejuif, Poitiers, Paris
2018-04-02
Active, closed
Development of Novel Clinical Endpoints in Intermediate AMD
NCT03349801Age Related Macular Degeneration (AMD)
Frank G. Holz
Observational
718
Créteil, Paris
2018-03-26
Active, closed
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD
NCT03458832Facioscapulohumeral Muscular Dystrophy
University of Kansas Medical Center
Observational
324
Nice, Paris
2018-03-05
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
16,000
Paris
2018-02-28
Recruiting
Octapharma
Observational
200
Besançon, Chambéry, Chambray-lès-Tours, Le Mans, Montmorency, Nantes, Paris, Saint-Priest-en-Jarez
2018-02-13
Active, closed
Institut National de la Santé Et de la Recherche Médicale, France
Observational
120
Paris
2018-02-06
Recruiting
Dabrafenib and/or Trametinib Rollover Study
NCT03340506Melanoma, Non Small Cell Lung Cancer, Solid Tumor, Rare Cancers
DrugsDabrafenib·Trametinib
Novartis Pharmaceuticals
Phase 4
100
Lyon, Nantes, Paris, Villejuif
2018-01-26
Active, closed
EBR Systems, Inc.
Not applicable
300
Grenoble, Paris, Rennes
2018-01-17
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
60
Paris
2018-01-11
Active, closed
Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN
NCT03386513Blastic Plasmacytoid Dendritic Cell Neoplasm, Myeloproliferative Neoplasm
DrugIMGN632
AbbVie
Phase 1/2
179
Amiens, Besançon, Marseille, Paris, Pessac
2018-01-02
Recruiting
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
NCT03142152Functional Mitral Regurgitation, Heart Failure, Mitral Valve Insufficiency, Heart Diseases
Cardiac Dimensions, Inc.
Not applicable
300
Clermont-Ferrand, Lille, Lyon, Montpellier, Paris
2018-01-01
Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
NCT03394365Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications, Lymphoproliferative Disorders, Allogeneic Hematopoietic Cell Transplant
DrugTabelecleucel
Pierre Fabre Medicament
Phase 3
115
Pessac, Lille, Paris
2017-12-29
Recruiting
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
NCT03328078Relapsed Hematologic Malignancy, Refractory Hematologic Malignancy, Relapsed Primary Central Nervous System Lymphoma, Refractory Primary Central Nervous System Lymphoma
DrugsEmavusertib·Ibrutinib
Curis, Inc.
Phase 1/2
152
Bordeaux, Marseille, Paris
2017-12-28
Active, closed
Impact of Platelet Activation in Intracranial Aneurysm Rupture Risk - PLAQRAN
NCT03408379Intracranial Aneurysms, Ruptured Aneurysm
Fondation Ophtalmologique Adolphe de Rothschild
Observational
230
Paris
2017-12-20
Recruiting
Impact of Epileptic Discharge on the Structural Connectivity of the Developing Brain
NCT03268824Epilepsies, Focal, Pediatrics, Drug Resistant Epilepsy
Fondation Ophtalmologique Adolphe de Rothschild
Observational
82
Paris
2017-12-19
Active, closed
Pfizer
Phase 3
1,054
Le Mans, Bayonne, Bordeaux, La Roche-sur-Yon, Lyon, Montpellier, Paris, Strasbourg
2017-12-18
Active, closed
AstraZeneca
Phase 2
528
Bordeaux, Nantes, Paris, Villejuif
2017-12-18
Recruiting
Registry for Patients With Lipodystrophy
NCT03553420Lipodystrophy Acquired, Lipodystrophy Congenital
University of Ulm
Observational
5,000
Lille, Paris
2017-12-16
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
100
Paris
2017-12-14
Active, closed
Gilead Sciences
Phase 3
340
Lyon, Paris
2017-12-12
Active, closed
Sanofi
Phase 3
475
Bayonne, Caen, Dijon, La Roche-sur-Yon, Lille, Nantes, Paris, Pessac
2017-12-07
Active, closed
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase 2
57
Avignon, Besançon, Créteil, Levallois-Perret, Lyon, Nantes, Paris, Poitiers
2017-12-04
Recruiting
Genetic Susceptibility to Listeriosis
NCT03357536Listeriosis
Institut Pasteur
Not applicable
100
Paris
2017-11-28
Active, closed
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2
160
Marseille, Montpellier, Vandœuvre-lès-Nancy, Perpignan, Caen, Paris, Rennes, Strasbourg
2017-11-01
Active, closed
ViiV Healthcare
Phase 3
1,049
Montpellier, Paris, Saint-Denis, Toulouse, Tourcoing
2017-10-27
Active, closed
Janssen-Cilag International NV
Observational
135
Argenteuil, Besançon, Bordeaux, Brest, Martigues, Paris, Saint-Etienne
2017-10-25
Recruiting
Italfarmaco
Phase 2/3
206
Nantes, Paris
2017-10-24
Recruiting
University Hospital, Brest
Observational
2,640
Brest, Clermont-Ferrand, Morlaix, Paris, Rennes, Saint-Etienne, Tours
2017-10-24
Active, closed
Centre Hospitalier Universitaire de Nīmes
Not applicable
240
Clermont-Ferrand, Lyon, Montpellier, Nîmes, Paris, Poitiers, Saint-Cyr-sur-Loire, Strasbourg
2017-10-17
Active, closed
Genzyme, a Sanofi Company
Phase 2
22
Nantes, Paris, Tours
2017-10-12
Active, closed
Emotional Regulation and Impulsivity Among Adolescents with Borderline Personality Disorder
NCT03209102Borderline Personality Disorder, Adolescent Development
Institut National de la Santé Et de la Recherche Médicale, France
Phase 2
66
Paris
2017-10-04
Recruiting
Apollomics Inc.
Phase 2
497
Brest, Lyon, Marseille, Paris, Villejuif
2017-09-27
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
885
Amiens, Arras, Bayonne, Beuvry, Grenoble, Lyon, Nantes, Paris
2017-09-25
Active, closed
Hoffmann-La Roche
Phase 2/3
1,000
Bordeaux, Caen, Lille, Lyon, Nîmes, Nouilly, Paris, Poitiers
2017-09-22
Active, closed
Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes.
NCT03246841Hereditary Breast and Ovarian Cancer, Mutation
UNICANCER
Not applicable
7,274
Paris
2017-09-21
Active, closed
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)
NCT03767348Non-Small Cell Lung Cancer (NSCLC), Microsatellite Instability-High (MSI-H), Non-melanoma Skin Cancer (NMSC), Cutaneous Melanoma
DrugsVusolimogene Oderparepvec·Opdivo·Nivolumab
Replimune, Inc.
Phase 2
340
Besançon, Bordeaux, Dijon, Lyon, Marseille, Nice, Paris, Villejuif
2017-09-20
Active, closed
Hoffmann-La Roche
Phase 3
382
Besançon, Grenoble, Lyon, Marseille, Nantes, Nice, Paris, Pierre-Bénite
2017-09-20
Recruiting
Mapping Epileptic Networks Using Multimodal Imaging
NCT06202976Epilepsy in Children
Imagine Institute
Observational
75
Paris
2017-09-14
Recruiting
Registry for Patients With X-Linked Hypophosphatemia
NCT03193476X-Linked Hypophosphatemia
Kyowa Kirin Pharmaceutical Development Ltd
Observational
1,489
Bordeaux, Bron, Lille, Montpellier, Nantes, Paris, Toulouse
2017-09-12
Active, closed
Centre Francois Baclesse
Phase 1/2
91
Amiens, Angers, Bordeaux, Caen, Le Havre, Lorient, Lyon, Paris
2017-09-04
Active, closed
Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers
NCT03260023HPV-Related Carcinoma, HPV-Related Cervical Carcinoma, HPV-Related Anal Squamous Cell Carcinoma, HPV-Related Penile Squamous Cell Carcinoma
DrugAvelumab
Transgene
Phase 1/2
143
Angers, Besançon, Bordeaux, Colmar, Dijon, Lyon, Marseille, Paris
2017-09-01
Active, closed
Rate of Progression in USH2A-related Retinal Degeneration
NCT03146078Usher Syndrome, Type 2A, Retinitis Pigmentosa 39
Jaeb Center for Health Research
Observational
127
Paris
2017-08-11
Active, closed
Astellas Gene Therapies
Phase 2/3
27
Paris
2017-08-02
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
1,200
Bordeaux, Caen, Limoges, Nancy, Nantes, Paris, Rennes, Suresnes
2017-07-13
Recruiting
Biology of Juvenile Myoclonic Epilepsy
NCT03400371Juvenile Myoclonic Epilepsy
King's College London
Observational
1,000
Paris
2017-07-13
Recruiting
National Cohort on Congenital Defects of the Eye
NCT05954403Anophthalmia, Microphthalmia, Aniridia, Anterior Segment Dysgenesis 6, Peters Anomaly Subtype
Institut National de la Santé Et de la Recherche Médicale, France
Observational
800
Paris
2017-07-11
Recruiting
Acostill ( RaDiCo Cohort) (RaDiCo Acostill)
NCT05927454Still Disease, Still's Disease, Adult-Onset, Still Disease, Juvenile Onset
Institut National de la Santé Et de la Recherche Médicale, France
Observational
500
Paris
2017-07-11
Active, closed
Hoffmann-La Roche
Phase 2
316
Bordeaux, Clermont-Ferrand, Créteil, Grenoble, Marseille, Nice, Paris, Poitiers
2017-06-27
Active, closed
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
NCT03165734Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis
DrugPacritinib
Swedish Orphan Biovitrum
Phase 3
407
Amiens, Nîmes, Marseille, Paris, Pessac, Pierre-Bénite, Poitiers
2017-06-26
Active, closed
MedSIR
Phase 2
377
Clermont-Ferrand, Nancy, Paris, Strasbourg, Toulouse
2017-06-26
Recruiting
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Observational
400
Paris
2017-06-08
Recruiting
Institut National de la Santé Et de la Recherche Médicale, France
Observational
700
Paris
2017-05-09
Active, closed
Osseointegration of THA Grafted by PolyNASS (ACTISURF-CERAFIT® ) Versus Non-grafted THA (CERAFIT®)
NCT03113981Osteoarthritis, Hip, Coxarthrosis; Primary, Coxarthrosis; Secondary, Osteonecrosis; Aseptic, Idiopathic
Societe ACTIVBIOMAT
Not applicable
340
Bordeaux, Boulogne-Billancourt, Brest, Paris, Quimper, Strasbourg
2017-05-08
Active, closed
Eli Lilly and Company
Phase 1/2
857
Bordeaux, Lyon, Marseille, Montpellier, Villejuif, Paris
2017-05-02
Recruiting
Centre Hospitalier Intercommunal Creteil
Observational
500
Créteil, Paris
2017-05-01
Active, closed
Pfizer
Phase 3
296
Pessac, Chevilly-Larue, Le Mans, Marseille, Paris, Rennes, Suresnes, Toulouse
2017-04-27
Recruiting
European Cystinosis Cohort
NCT05901077Cystinosis
Institut National de la Santé Et de la Recherche Médicale, France
Observational
400
Paris
2017-04-20
Active, closed
Institut Curie
Not applicable
88
Paris
2017-03-19
Recruiting
Identifying New Genetic Causes to Development Disorders
NCT03283852Disorders of Sex Development, Growth Disorders, Puberty Disorders
Fondation Ophtalmologique Adolphe de Rothschild
Observational
1,100
Paris
2017-02-21
Active, closed
Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
NCT03069469Advanced Malignant Neoplasm, Pigmented Villonodular Synovitis, Giant Cell Tumor of Tendon Sheath, Tenosynovial Giant Cell Tumor
DrugVimseltinib
Deciphera Pharmaceuticals, LLC
Phase 1/2
120
Lyon, Paris
2017-02-16
Recruiting
French National Registry of Bone Marrow Failures
NCT04781790Bone Marrow Failure Syndrome
Assistance Publique - Hôpitaux de Paris
Observational
5,000
Paris
2017-02-06
Active, closed
AbbVie
Phase 3
443
Pessac, Angers, Paris, Toulouse
2017-02-02
Active, closed
Acerta Pharma BV
Phase 3
310
Bordeaux, Brest, Montpellier, Nantes, Paris, Perpignan, Provence Alpes Cote D'Azur, Rennes
2017-02-02
Active, closed
The Netherlands Cancer Institute
Phase 3
174
Marseille, Paris
2017-01-25
Recruiting
Institut Curie
Not applicable
1,050
Bordeaux, Lille, Lyon, Paris, Saint-Cloud, Vandœuvre-lès-Nancy
2017-01-06
Recruiting
Cardio-Oncology Registry
NCT04407780Cancer, Cardiac Disease, Metabolic Syndrome, Arrhythmia
European Georges Pompidou Hospital
Observational
5,000
Paris
2017-01-01
Active, closed
Feasibility of Molecular Biology in Pancreatic Cyst Tumors
NCT03305146Pancreatic Cyst, Pancreas Cyst, Serous Cystadenoma, Mucinous Cystadenoma
Hospital St. Joseph, Marseille, France
Not applicable
93
Charenton-le-Pont, Limoges, Lyon, Marseille, Nantes, Nice, Paris, Vichy
2017-01
Active, closed
Astellas Pharma Global Development, Inc.
Phase 2
900
Bordeaux, La Roche-sur-Yon, Lille, Lyon, Montpellier, Nîmes, Paris, Saint-Herblain
2016-12-22
Active, closed
Management of Symptomatic Advanced Pancreatic Adenocarcinoma
NCT02979483Pancreas, Management Supportive Care Program
GERCOR - Multidisciplinary Oncology Cooperative Group
Not applicable
110
Avignon, Clichy, Créteil, Levallois-Perret, Lyon, Mont-de-Marsan, Paris, Thonon-les-Bains
2016-12-19
Recruiting
Population Pharmacokinetics of Anti-infectives in Hospitalized Patients
NCT02998411Patient Receiving Anti-infectives Whatever Disease
Assistance Publique - Hôpitaux de Paris
Observational
60
Paris
2016-12-01
Active, closed
Target PharmaSolutions, Inc.
Observational
10,000
Nice, Paris
2016-12
Active, closed
Eli Lilly and Company
Phase 1
223
Paris, Lille, Villejuif
2016-11-21
Recruiting
University Hospital, Lille
Not applicable
120
Clermont-Ferrand, Lille, Paris, Poissy, Rouen
2016-11-17
Recruiting
Genetic of Intellectual Deficiency and Autism Spectrum Disorders (RaDiCo-GenIDA)
NCT06871696Genetic of Intellectual Deficiency, Autism Spectrum Disorder
Institut National de la Santé Et de la Recherche Médicale, France
Observational
1,000
Paris
2016-11
Active, closed
ViiV Healthcare
Phase 3
618
Montpellier, Paris, Saint-Denis, Toulouse, Tourcoing
2016-10-28
Active, closed
ViiV Healthcare
Phase 3
631
Bobigny, Lyon, Marseille, Paris
2016-10-27
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
100
Clichy, Paris
2016-10-16
Active, closed
Eisai Inc.
Phase 3
1,069
Angers, Dijon, Le Mans, Lyon, Montpellier, Paris, Saint-Herblain, Strasbourg
2016-10-13
Recruiting
MEASuRE: Metreleptin Effectiveness And Safety Registry
NCT02325674Generalised Lipodystrophy, Partial Lipodystrophy
DrugMetreleptin
Chiesi Farmaceutici S.p.A.
Observational
100
Lille, Paris
2016-10-11
Recruiting
French Cardiology Society
Observational
500
Lyon, Nantes, Paris
2016-10
Recruiting
Groupe Hospitalier Diaconesses Croix Saint-Simon
Phase 2
84
Dijon, Levallois-Perret, Paris, Poissy, Poitiers, Senlis
2016-10
Active, closed
Fondation Ophtalmologique Adolphe de Rothschild
Observational
400
Paris
2016-09-08
Recruiting
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Observational
2,000
Paris
2016-09-01
Recruiting
University Hospital, Grenoble
Not applicable
60
Créteil, Grenoble, Nice, Paris
2016-09
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1/2
472
Villejuif, Angers, Bordeaux, Lille, Lyon, Marseille, Nantes, Paris
2016-08-03
Active, closed
iSTAR Medical
Observational
70
Lyon, Paris
2016-07
Active, closed
AGO Study Group
Not applicable
797
Bordeaux, Paris, Villejuif
2016-07
Active, closed
PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer
NCT03469674Endometrial Cancer Stage I, Endometrial Cancer Stage II
Leiden University Medical Center
Phase 3
550
Paris
2016-06-10
Active, closed
Celgene
Phase 1/2
130
Lille, Marseille, Paris, Pessac, Pierre-Bénite, Toulouse, Villejuif
2016-06-03
Recruiting
Institut Bergonié
Not applicable
205
Bordeaux, Dijon, Lille, Lyon, Marseille, Nantes, Paris, Toulouse
2016-06
Active, closed
Janssen Research & Development, LLC
Phase 1
751
Bordeaux, Dijon, Lyon, Marseille, Paris, Saint-Herblain, Villejuif
2016-05-24
Recruiting
Molecular Genetic Study of Mayer-Rokitansky-Kuster-Hauser Syndrome
NCT02967822Mayer Rokitansky Kuster Hauser Syndrome
Imagine Institute
Observational
410
Paris
2016-05
Recruiting
Hôpital Necker-Enfants Malades
Not applicable
75
Paris
2016-05
Active, closed
AstraZeneca
Phase 1/2
264
Bordeaux, Caen, Clermont-Ferrand, Dijon, Marseille, Nantes, Paris, Pierre Benit Cedex
2016-03-17
Active, closed
Tesaro, Inc.
Phase 1
729
Bordeaux, Caen, Clermont-Ferrand, Lille, Marseille, Paris, Saint-Herblain, Villejuif
2016-03-07
Active, closed
ReCor Medical, Inc.
Not applicable
282
Bordeaux, Lille, Lyon, Paris, Toulouse
2016-03
Recruiting
The Oxford Risk Factors And Non-Invasive Imaging Study
NCT05169333Cardiovascular Diseases, Cardiovascular Risk Factors
University of Oxford
Observational
250,000
Paris
2016-02-23
Recruiting
University Hospital, Lille
Observational
85
Amiens, Bron, Lille, Marseille, Montpellier, Paris, Strasbourg
2016-02-03
Active, closed
BioMarin Pharmaceutical
Phase 2
30
Paris
2016-01-26
Recruiting
University of Alberta
Observational
900
Paris
2016-01
Recruiting
Genotype-phenotype Characterization Study on Genetic Diseases With Immune and Neurological Dysfunctions
NCT06235580Genetic Diseases, Immune Dysfunction, Neurological Disease, Autoimmune Diseases
Imagine Institute
Observational
1,000
Paris
2015-12-28
Recruiting
Genetic and Electrophysiologic Study in Focal Drug-resistant Epilepsies
NCT02890641Drug-resistant Focal Epilepsies in Pediatric Population
Fondation Ophtalmologique Adolphe de Rothschild
Observational
450
Paris
2015-12-17
Active, closed
Bayer
Phase 1/2
154
Paris, Villejuif
2015-12-16
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
60
Paris
2015-12-15
Active, closed
Novartis Pharmaceuticals
Phase 4
233
Paris, Saint-Herblain, Strasbourg, Villejuif
2015-12-11
Active, closed
AbbVie
Phase 3
1,629
Toulouse, Lille, Montpellier, Bordeaux, Caen, Clermont-Ferrand, Marseille, Paris
2015-12-01
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
500
Paris
2015-12
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
1,052
Clermont-Ferrand, Montpellier, Nancy, Paris, Pierre-Bénite, Strasbourg, Suresnes
2015-11-27
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
1,000
Paris
2015-11-26
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
2,000
Paris
2015-11-25
Active, closed
Hoffmann-La Roche
Phase 2
534
Angers, Bordeaux, Lyon, Marseille, Montpellier, Paris, Toulouse, Villejuif
2015-11-19
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
5,000
Paris
2015-11-12
Recruiting
CAR-T Long Term Follow Up (LTFU) Study
NCT02445222Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
Novartis Pharmaceuticals
Phase 3
1,105
Nantes, Paris, Pessac, Pierre-Bénite, Strasbourg, Villejuif
2015-11-02
Active, closed
AstraZeneca
Phase 3
1,126
Bordeaux, Caen, Lyon, Marseille, Paris, Poitiers, Suresnes, Toulouse
2015-11-02
Active, closed
AstraZeneca
Phase 3
682
Bron, Lille, Limoges, Lyon, Paris
2015-10-21
Active, closed
French Cardiology Society
Observational
5,000
Paris
2015-10
Active, closed
Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)
NCT02215265Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer
DrugCisplatin
Lisette Nixon
Phase 3
1,269
Paris
2015-10
Recruiting
Fondation Ophtalmologique Adolphe de Rothschild
Observational
220
Paris
2015-09-24
Recruiting
Cohort of Prosthetic Joint Infections
NCT02801253Prosthetic Joint Infection
Groupe Hospitalier Diaconesses Croix Saint-Simon
Observational
800
Paris
2015-09-11
Recruiting
Population Pharmacokinetics of Anti-infectives in Critically Ill Children
NCT02539407Pediatric Intensive Care Unit, Pediatric Immuno-hematology Department
Assistance Publique - Hôpitaux de Paris
Observational
3,000
Paris
2015-09-11
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 4
820
Bordeaux, Paris
2015-09
Recruiting
Simple Mechanical Device to Control Pressure in the Balloon of the Endotracheal Tube to Prevent Ventilator-acquired Pneumonia
NCT02514655Mechanical Ventilation, Tracheal Intubation, Ventilator-acquired Pneumonia, Intubation -Related Tracheal Lesions
Assistance Publique - Hôpitaux de Paris
Not applicable
500
Paris
2015-08-15
Active, closed
Alliance for Clinical Trials in Oncology
Phase 3
420
Lyon, Marseille, Paris, Strasbourg, Toulouse, Vandœuvre-lès-Nancy, Villejuif
2015-08-06
Recruiting
Saint Antoine University Hospital
Observational
825
Paris, Saint-Denis, Toulouse
2015-07-27
Active, closed
Eli Lilly and Company
Phase 3
545
Montpellier, La Tronche, Lille, Poitiers, Paris
2015-05-06
Recruiting
Surgery for Recurrent Glioblastoma
NCT02394626Glioblastoma
Insel Gruppe AG, University Hospital Bern
Phase 2
120
Dijon, Lyon, Marseille, Nice, Paris, Saint-Etienne, Strasbourg, Tours
2015-05-01
Recruiting
The European NAFLD Registry
NCT04442334NAFLD, NASH, NASH - Nonalcoholic Steatohepatitis, Fibrosis, Liver
Newcastle University
Observational
10,000
Angers, Paris
2015-05-01
Active, closed
Janssen Research & Development, LLC
Phase 2
239
Angers, Bordeaux, Caen Cédex 05, Dijon, Lyon, Nice, Nîmes, Paris
2015-04-22
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
370
Paris
2015-03-19
Active, closed
CINC424A2X01B Rollover Protocol
NCT02386800Primary Myelofibrosis, Polycythemia Vera, Graft Versus Host Disease, Acute Myeloid Leukemia
DrugsPanobinostat·Jakavi·Ruxolitinib
Novartis Pharmaceuticals
Phase 4
279
Paris
2015-03-05
Active, closed
Exelixis
Phase 4
247
Bordeaux, Angers, Lyon, Villejuif, Dijon, Paris, Strasbourg
2015-02-25
Active, closed
ViiV Healthcare
Phase 3
371
Bordeaux, Marseille, Nantes, Paris
2015-02-23
By invitation
Registry of Patients With Hypophosphatasia
NCT02306720Hypophosphatasia (HPP)
Alexion Pharmaceuticals, Inc.
Observational
1,571
Toulouse, Lille, Paris, Poitiers, Lyon, Le Kremlin-Bicêtre
2015-01-20
Active, closed
Icahn School of Medicine at Mount Sinai
Observational
2,145
Talence, Paris
2015-01-13
Active, closed
A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)
NCT02912949Solid Tumours Harboring NRG1 Fusion, NSCLC Harboring NRG1 Fusion, Pancreatic Cancer Harboring NRG1 Fusion, NRG1 Fusion
Partner Therapeutics, Inc.
Phase 2
250
Lyon, Paris
2015-01
Active, closed
Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma
NCT02243605Metastatic Ewing Sarcoma, Metastatic Osteosarcoma, Recurrent Ewing Sarcoma, Recurrent Osteosarcoma
DrugsCabozantinib S-malate·Cabozantinib
National Cancer Institute (NCI)
Phase 2
90
Bordeaux, Dijon, Lille, Lyon, Marseille, Nice, Paris, Saint-Herblain
2014-12-19
Active, closed
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
NCT02319837Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
DrugsLupron·Eligard·Leuprorelin·Xtandi
Pfizer
Phase 3
1,068
Angers, Brest, La Roche-sur-Yon, Lille, Montpellier, Nantes, Paris, Saint-Grégoire
2014-12-17
Active, closed
ETOP IBCSG Partners Foundation
Not applicable
518
Bordeaux, Lille, Lyon, Paris
2014-12-04
Active, closed
Aragon Pharmaceuticals, Inc.
Phase 3
982
Angers, Caen, Dijon, Le Mans, Lyon, Montpellier, Paris, Saint-Herblain
2014-11-26
Recruiting
Immuno-Genetic, Inflammation, Retro-Virus, Environment
NCT02878408Bipolar Disorder, Schizophrenia
Pr. Marion Leboyer
Not applicable
1,100
Créteil, Bordeaux, Paris, Pontoise
2014-11-07
Active, closed
Institut National de la Santé Et de la Recherche Médicale, France
Observational
385
Paris
2014-11-06
Active, closed
Karyopharm Therapeutics Inc
Phase 2
244
Pierre-Bénite, Créteil, Dijon, La Rochelle, Lille, Marseille, Montpellier, Paris
2014-11
Active, closed
UNICANCER
Phase 2
216
Paris
2014-10-13
Active, closed
Acerta Pharma BV
Phase 2
107
Aurillac, Clermond Ferrand, Marseille, Montpellier, Nantes, Paris, Pierre-Bénite, Poitiers
2014-09-11
Active, closed
Genethon
Phase 1/2
10
Paris
2014-09
Active, closed
AbbVie
Observational
1,446
Bron, Paris
2014-08-28
Recruiting
Imagine Institute
Observational
1,445
Bordeaux, Bron, Lille, Marseille, Paris, Rennes, Strasbourg, Toulouse
2014-06-16
Active, closed
Universitätsklinikum Hamburg-Eppendorf
Phase 2/3
360
Grenoble, Paris, Tours, Vandœuvre-lès-Nancy
2014-06
Active, closed
PERIGON Pivotal Trial
NCT02088554Aortic Stenosis
Medtronic Cardiac Surgery
Not applicable
1,312
Bordeaux, Paris
2014-05-12
Recruiting
St. Justine's Hospital
Observational
1,200
Paris
2014-05
Active, closed
University Hospital, Toulouse
Observational
1,700
Bordeaux, Clichy, Lille, Lyon, Marseille, Montpellier, Nice, Paris
2014-05
Recruiting
Observational Study to Evaluate Long-Term Outcome in Hip Arthroplasty
NCT02230826Hip Replacement, Primary, Secondary or Post-traumatic Osteoarthrosis, Femur Head Necrosis, Congenital Dislocations
Corin
Observational
2,500
Bordeaux, Cannes, Dunkirk, Hénin-Beaumont, Nice, Orléans, Paris, Pessac
2014-05
Recruiting
Chronic Myeloid Leukemia (CML) Real-Life Database
NCT05963061Chronic Myeloid Leukemia (CML)
University Hospital, Clermont-Ferrand
Observational
3,500
Annecy, Caen, Clermont-Ferrand, Le Puy-en-Velay, Limoges, Marseille, Nancy, Paris
2014-04-16
Recruiting
Boston Scientific Corporation
Observational
1,500
Créteil, Lyon, Marseille, Paris, Rennes
2014-03-04
Recruiting
Centre Leon Berard
Phase 2
900
Bordeaux, Lyon, Marseille, Paris, Strasbourg, Toulouse
2014-03
Active, closed
Brain Injury and Cognitive Function
NCT05922748Cerebral Lesion, Cognitive Deficit Following Brain Lesions
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
1,500
Paris
2014-02-05
Active, closed
Genetix Biotherapeutics Inc.
Observational
66
Marseille, Paris
2014-01
Recruiting
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Observational
120
Paris
2014-01
Active, closed
Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma
NCT01979523Recurrent Uveal Melanoma, Stage IV Uveal Melanoma AJCC v7
DrugTrametinib
National Cancer Institute (NCI)
Phase 2
42
Paris
2013-11-21
Active, closed
Assistance Publique - Hôpitaux de Paris
Observational
362
Paris
2013-11-12
Active, closed
Novartis Pharmaceuticals
Phase 1/2
259
Marseille, Paris, Saint-Herblain
2013-10-22
Active, closed
AstraZeneca
Phase 3
510
Brest, Caen, Clermont-Ferrand, Dijon, Lille, Marseille, Paris, Pierre-Bénite
2013-09-25
Active, closed
Sanofi
Phase 2
9
Paris
2013-09-12
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
DrugIbrutinib
Janssen Research & Development, LLC
Phase 3
539
Créteil, Mulhouse, Paris, Pessac, Pierre-Bénite, Tours
2013-09-09
Active, closed
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
NCT01874353Platinum Sensitive, BRCA Mutated, Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemotherapy
DrugOlaparib
AstraZeneca
Phase 3
327
Bordeaux, Caen, Lyon, Nantes, Paris, Pierre-Bénite, Saint-Cloud, Toulouse
2013-09-03
Recruiting
French Observatory for Patients with Type 3 Glycogenosis
NCT06616545Glycogen Storage Disease Type III
Institut de Myologie, France
Observational
150
Clamart, Le Kremlin-Bicêtre, Paris
2013-09-01
Active, closed
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV, BRCA Mutation
DrugOlaparib
AstraZeneca
Phase 3
450
Bordeaux, Caen, Lyon, Nantes, Paris, Vandœuvre-lès-Nancy, Villejuif
2013-08-26
Recruiting
Gustave Roussy, Cancer Campus, Grand Paris
Observational
10,000
Villejuif, Lyon, Paris
2013-07-23
Active, closed
DIGItal Cohort Osteoarthritis Design
NCT01831570Arthrosis of Hand
Assistance Publique - Hôpitaux de Paris
Not applicable
500
Paris
2013-04
Recruiting
Institut National de la Santé Et de la Recherche Médicale, France
Not applicable
180
Paris
2013-02
Active, closed
Bristol-Myers Squibb
Observational
800
Clermont-Ferrand, Paris, Toulouse
2013-01-30
Active, closed
Sanofi
Phase 2
27
Paris
2012-12-14
Active, closed
Washington University School of Medicine
Phase 2/3
490
Toulouse, Lille, Paris, Bron, Rouen
2012-12
Recruiting
French Prospective Anterior Cruciate Ligament Reconstruction Cohort Study (FAST)
NCT02511158Rupture of Anterior Cruciate Ligament, Osteoarthritis
Fonds de Dotation pour la Recherche Clinique en Orthopédie et Pathologie du Sport
Observational
7,000
Paris
2012-09
Active, closed
Eli Lilly and Company
Phase 2
110
Paris
2012-05-22
Recruiting
Patient Retrospective Outcomes (PRO)
NCT01550575Chronic Pain
Boston Scientific Corporation
Observational
15,000
Caen, Créteil, Lyon, Nantes, Paris, Poitiers, Saint-Herblain, Suresnes
2012-04-03
Active, closed
Conservative Treatments of Retinoblastoma
NCT02866136Retinoblastoma, Children, Retinal Neoplasm
DrugsMelphalan·Vincristine·Etoposide·Carboplatin
Institut Curie
Phase 2
133
Paris
2012-02
Active, closed
Radical Fimbriectomy for Young BRCA Mutation Carriers
NCT01608074BRCA1 Mutation, BRCA2 Mutation, Hereditary Breast and Ovarian Cancer
Centre Oscar Lambret
Not applicable
123
Aix-en-Provence, Bordeaux, Clermont-Ferrand, Lille, Lyon, Marseille, Nice, Paris
2012-01-09
Active, closed
HIV Patients Cohort
NCT02203006Patients Affected by the HIV
Assistance Publique - Hôpitaux de Paris
Not applicable
1,613
Paris
2011-10-19
Recruiting
Diagnostic and Therapeutic Applications in Microarrays in Organ Transplantation
NCT01299168Validation Study of Molecular Diagnostic System, Development of Reporting System for Molecular Diagnosis, Incorporate Molecular Diagnosis Into Diagnostic Standards
University of Alberta
Observational
500
Paris
2011-05
Active, closed
Vismodegib in Treating Patients With Advanced Chondrosarcomas
NCT01267955Clear Cell Chondrosarcoma, Dedifferentiated Chondrosarcoma, Locally Advanced Chondrosarcoma, Mesenchymal Chondrosarcoma
DrugVismodegib
National Cancer Institute (NCI)
Phase 2
45
Bordeaux, Lille, Lyon, Marseille, Paris, Villejuif
2010-12-21
Recruiting
French National Registry of Patients With Tetralogy of Fallot and Implantable Cardioverter Defibrillator
NCT03837574Tetralogy of Fallot, Implantable Defibrillator User, Congenital Heart Disease, Sudden Cardiac Death
Paris Sudden Death Expertise Center
Observational
150
Paris
2010-12-01
Recruiting
OBS'CEREVANCE: French Cohort of Pediatric Autoimmune Cytopenia
NCT05937828Immune Thrombocytopenia, Autoimmune Hemolytic Anemia, Evans Syndrome
University Hospital, Bordeaux
Observational
3,500
Amiens, Angers, Besançon, Bordeaux, Brest, Caen, Clermont-Ferrand, Paris
2010-09-01
Recruiting
Saint Antoine University Hospital
Observational
800
Paris
2010-02
Recruiting
Centre Hospitalier Universitaire de Nice
Observational
40
Nice, Lille, Marseille, Nantes, Nîmes, Paris, Poitiers, Rennes
2010-01-01
Recruiting
French Hypertrophic Cardiomyopathy Observatory
NCT01091480Hypertrophic Cardiomyopathy
French Cardiology Society
Observational
600
Paris
2010-01
Active, closed
Clinical Course of Interstitial Lung Diseases: European IPF Registry and Biobank
NCT02951416Idiopathic Pulmonary Fibrosis, Idiopathic Interstitial Pneumonia, Interstitial Lung Diseases, Diffuse Parenchymal Lung Diseases
Andreas Guenther
Observational
2,000
Dijon, Paris
2009-09
Active, closed
Minimal SN Tumor Burden
NCT01942603Cutaneous Melanoma
European Organisation for Research and Treatment of Cancer - EORTC
Observational
296
Lille, Nice, Paris
2009-07
Active, closed
Genentech, Inc.
Phase 2
378
Caen, Dijon, Marseille, Montpellier, Paris, Saint-Cloud, Saint-Herblain
2008-10-16
Active, closed
Heart Rate, Baroreflex Sensitivity and Cardiovascular Morbidity and Mortality in the Population
NCT00741728Community Based Study, Cardiovascular Disease, Sudden Death, Blood Pressure
Institut National de la Santé Et de la Recherche Médicale, France
Observational
10,157
Paris
2008-05-13
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
751
Marseille, Nancy, Nice, Paris, Rennes, Villejuif
2007-12
Recruiting
Registry of Coronary Artery Ill Patients With Platelet Test Results
NCT02762162Acute Coronary Syndrome, Percutaneous Coronary Intervention, Myocardial Infarction
Action, France
Observational
5,000
Paris
2007-01
Recruiting
Assistance Publique - Hôpitaux de Paris
Observational
5,300
Paris
2006-05
Recruiting
Postoperative Morbidity and Mortality After Cardiac Surgery
NCT03393169Cardiac Surgery Under Extra Corporeal Circulation
Assistance Publique - Hôpitaux de Paris
Observational
12,000
Paris
2006-01-01
Recruiting
University Hospital, Gasthuisberg
Observational
5,000
Paris
2005-08
Recruiting
The EUROSCA Natural History Study
NCT02440763Spinocerebellar Ataxia
Ataxia Study Group
Observational
400
Paris
2005-07
Recruiting
French Wilson Disease Registry
NCT05231876Wilson Disease
Fondation Ophtalmologique Adolphe de Rothschild
Observational
1,000
Paris
2005-01-01
Recruiting
Birdshot Chorioretinopathy : Prospective Follow-up and Immunogenetic Studies(CO-BIRD)
NCT05153057Birdshot Chorioretinopathy, Posterior Uveitis
Assistance Publique - Hôpitaux de Paris
Observational
600
Paris
2004-11-02
Recruiting
Adult Pulmonary Langerhans Cell Histiocytosis: a National Registry-based Prospective Cohort Study
NCT04665674Histiocytosis, Histiocytosis, Langerhans-Cell, Histiocytosis Pulmonary
Assistance Publique - Hôpitaux de Paris
Observational
500
Paris
2004-01-01
Recruiting
GERCOR - Multidisciplinary Oncology Cooperative Group
Observational
4,050
Besançon, Clichy, Créteil, Lille, Lyon, Nancy, Paris, Poitiers
2003-01-01
Recruiting
Proximal Hamstring Avulsion Surgery Cohort Study
NCT02906865Proximal Hamstring Rupture
Fonds de Dotation pour la Recherche Clinique en Orthopédie et Pathologie du Sport
Observational
1,000
Paris
2002-01
Recruiting
Centre de Recherche sur les Pathologies Prostatiques
Observational
10,000
Angers, Brest, Dijon, Paris
1996-10
By invitation
Copenhagen University Hospital, Rigshospitalet
Observational
23,000
Bordeaux, Lyon, Nice, Paris
1994-01
Recruiting
Nantes University Hospital
Observational
30,000
Lyon, Montpellier, Nancy, Nice, Paris, Toulouse
1994-01
Active, closed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
615
Bordeaux, Caen, Compiègne, Dijon, Lyon, Nice, Paris, Pierre-Bénite
1989-09
Rows per page Showing 2501–2823 of 2823
Previous 4 5 6
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 30 October 2026. https://priyalifescience.com/clinical-trials-france/city/paris?page=6

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,722 studies in total at the last sync on 29 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 2,823 of those studies with a site in Paris.

How many clinical trials are recruiting in Paris?

1,625 of the 2,823 studies on this page are recruiting new participants as of the 29 Oct 2026, 03:20 UTC sync. A further 323 have not yet opened recruitment, 828 are active but closed to new participants, and 47 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.